Pulmatrix Gets $30M And An NIH Grant To Develop A Broad-Spectrum Anti-Infective
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotech's technology uses two mechanisms of action to prevent infection and keep pathogens from entering the lungs.